Page last updated: 2024-10-27

flucytosine and Mycoses

flucytosine has been researched along with Mycoses in 289 studies

Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.

Mycoses: Diseases caused by FUNGI.

Research Excerpts

ExcerptRelevanceReference
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks."7.69Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995)
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis."7.68In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992)
"This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions."7.68Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990)
"A 27-year-old man sustained a thorn injury to his left eye and a culture-proven Fusarium oxysporum endophthalmitis developed."7.66Fusarium oxysporum endophthalmitis. ( Acers, TE; Mohr, JA; Newsom, DL; Rodriguez, J; Rowsey, JJ; Smith, DL, 1979)
"Fusarium pathogen is an uncommon cause of infections in ophthalmology."5.28[Endophthalmitis due to Fusarium: an uncommon cause]. ( Berthe-Bonnet, S; Comhaire-Poutchinian, Y; Cremer, V; Grek, V, 1990)
"Flucytosine (5-FC), an oral antifungal agent, was used in the treatment of 37 patients with urinary tract infections due to fungi."5.07[Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors]. ( Ban, Y; Ehara, H; Fujihiro, S; Ito, Y; Kanematu, M; Kawada, Y; Saito, A, 1991)
"The oral agents for deep-seated mycoses that can be used in Japan are amphotericin B, flucytosine, fluconazole, itraconazole, and voriconazole."4.84[Oral antifungal agents]. ( Maesaki, S; Tarumoto, N, 2008)
" These events have lead to the development of new antifungal agents, and amphotericin B no longer is the standard therapy for a variety of invasive mycoses."4.80Therapy of invasive fungal infections. ( de Pauw, BE; Kullberg, BJ, 1999)
" Amphotericin B, drug of choice for most invasive mycoses, has unique pharmacokinetic properties, binding initially to serum lipoproteins and redistributing from blood to tissues."4.78Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. ( Lyman, CA; Walsh, TJ, 1992)
"Flucytosine is an antifungal agent useful in combination with amphotericin B in the treatment of several deeply invasive mycoses."4.78Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. ( Francis, P; Walsh, TJ, 1992)
"We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia."4.77Diagnosis and successful treatment of fusariosis in the compromised host. ( Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG, 1988)
" Two distinct eras of rapid progress in antifungal therapy followed: first, in the 1950's came the introduction of the polyenes, nystatin and pimaricin for cutaneous, vaginal and intestinal candidiasis, and amphotericin B for the treatment of severe systemic mycoses."4.76Progress in antimycotic chemotherapy 1945-1980. ( Holt, RJ, 1980)
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B 1-2 mg and oral flucytosine or fluconazole 50 mg b."3.69Successful treatment of fungal peritonitis with intracatheter antifungal retention. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995)
"Two patients who developed fungal peritonitis after receiving continuous ambulatory peritoneal dialysis (CAPD) for various periods were successfully treated with intracatheter retention of amphotericin B and oral flucytosine for 5 weeks."3.69Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. ( Chiang, SS; Hseih, SJ; Lee, SH; Shen, HM, 1995)
" Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis."3.68In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992)
"This report describes two cases of peritoneal dialysis-related peritonitis caused by Fusarium species which have been incriminated in a variety of disease conditions."3.68Fusarium peritonitis in peritoneal dialysis: report of two cases. ( Chiaradia, V; Pascoli, L; Santini, GF; Schinella, D; Tesio, F, 1990)
"Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios."3.67Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987)
"Numerous progresses are realized in the chemotherapy of mycoses, particularly in the field of deep mycoses due to 3 categories of systemic antifungal agents: polyenes (oral nystatin, oral and intravenous amphotericin B), 5-fluorocytosine (oral and intravenous) and imidazole derivatives (oral and intravenous miconazole, oral ketoconazole)."3.66[Antifungal agents in otorhinolaryngology]. ( Drouhet, E; Dupont, B, 1982)
"The author presents the drugs that are available for the treatment of opportunistic mycoses: amphotericin B, nystatin, 5-fluorocytosine, miconazole and the newest imidazole derivative econazole."3.66[Therapy of opportunistic mycoses]. ( Negroni, R, 1979)
" Despite surgical excision and therapy with the antifungal drugs amphotericin B and flucytosine, the case had a fatal outcome, the patient dying from a pulmonary embolism 6 mth after the onset of symptoms."3.66Cerebral abscess caused by Cladosporium bantianum. Case report. ( Wilson, E, 1982)
"A 27-year-old man sustained a thorn injury to his left eye and a culture-proven Fusarium oxysporum endophthalmitis developed."3.66Fusarium oxysporum endophthalmitis. ( Acers, TE; Mohr, JA; Newsom, DL; Rodriguez, J; Rowsey, JJ; Smith, DL, 1979)
" Amphotericin B is the single most important antifungal agent for the treatment of systemic mycoses."3.66Drugs for fungal infections. ( Yoshikawa, TT, 1980)
"Two different flucytosine (5-FC) treatment regimens, one by itself and the other in combination with fluconazole (FLCZ) were compared in chemotherapy against mycotic infections in 60 patients with hematological diseases."2.67[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method]. ( Ariyoshi, H; Hamajima, N; Hotta, T; Kodera, Y; Murate, T; Naito, K; Naoe, T; Ogura, M; Saito, H; Tanaka, M, 1994)
" Antimicrobial pharmacokinetic/pharmacodynamic (PK/PD) studies consider these variables and have been useful in drug development, optimizing dosing regimens, determining susceptibility breakpoints, and limiting toxicity of antifungal therapy."2.50Antifungal pharmacokinetics and pharmacodynamics. ( Andes, DR; Lepak, AJ, 2014)
" This article reviews the pharmacokinetic profiles of these drugs in children, with a focus on the age-related changes."2.47[Pharmacokinetics and pharmacodynamics of antifungal drugs in children]. ( Jullien, V, 2011)
" Antifungal serum concentrations may aid in the determination of appropriate dosing in select circumstances."2.44Antifungal serum concentration monitoring: an update. ( Drew, RH; Goodwin, ML, 2008)
"Therapeutic drug monitoring of any pharmacologic agent should be considered when there is both significant pharmacokinetic variability and strong, clinically relevant, exposure-effect relationships."2.44Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. ( Andes, D; Smith, J, 2008)
"Amphotericin B was the standard of care for most of these infections."2.43Management of systemic fungal infections: alternatives to itraconazole. ( Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y, 2005)
"Invasive fungal infections have increased in frequency and severity over the past two decades as a result of an increasing number of immunocompromised patients."2.43Antifungal treatment in pediatric patients. ( Benjamin, DK; Steinbach, WJ; Zaoutis, TE, 2005)
" This article provides an up-to-date review on the clinical pharmacology, indications, and dosage recommendations of approved and currently investigational therapeutics for treatment of invasive fungal infections in adult and pediatric patients."2.42Clinical pharmacology of antifungal compounds. ( Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ, 2003)
"Fungal infections are life-threatening complications in patients with prolonged neutropenia."2.41Standard antifungal therapy in neutropenic patients. ( Aoun, M, 2000)
"Amphotericin B has a broad spectrum and has remained the drug of choice for these life threatening invasive fungal infections."2.41[Choice and use of antifungal drugs]. ( Dupont, B, 2001)
" 5-FC is well absorbed after oral administration, penetrates into body tissues well and is excreted mainly by the kidneys."2.41Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. ( Dankert, J; Guchelaar, HJ; Vermes, A, 2000)
" The bioavailability of fluconazole is much less varied although validation of compliance is a situation where obtaining serum concentrations may provide additional information."2.40Therapeutic drug monitoring of systemic antifungal therapy. ( Gore, SJ; Graybill, JR; Hardin, TC; Summers, KK, 1997)
"Fungal infections have emerged as a major complication of marrow transplantation in children."2.39Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients. ( Chanock, SJ; Walsh, TJ, 1996)
" Liposomal Amphotericin B allowing higher dosage by lower toxicity appears effective as salvage treatment especially in aspergillosis which also responds to Itraconazole available as oral formulation so far."2.38Antifungal treatment strategy in leukemia patients. ( Büchner, T; Roos, N, 1992)
"Treatment with amphotericin B and 5-fluorocytosine was initiated."2.38Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature. ( Galbraith, J; Garg, AK; Mielke, BW; Sekhon, AS; Sheehan, G, 1992)
"Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients."2.37Recent advances in the treatment of systemic fungal infections. ( Walsh, TJ, 1987)
"Superficial fungal infections are frequent and can cause considerable morbidity."2.37Topical and systemic antifungal agents. ( Bodey, GP, 1988)
"The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas."2.37Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986)
"Flucytosine is a systemic antifungal drug that is readily absorbed from the gastrointestinal tract."2.36Flucytosine. ( Bennet, JE, 1977)
"Amphotericin B has remained the most effective therapeutic preparation for most types of neurological fungal disease, although important roles for 5-fluorocytosine, miconazole, and, more recently, ketoconazole are being recognized."2.36Treatment of fungal infections of the central nervous system. ( Bell, WE, 1981)
"Miconazole is a parenterally administered agent for patients acutely ill with candidiasis and other mycotic infections."2.36Antifungal agents used in systemic mycoses. Activity and therapeutic use. ( Craven, PC; Graybill, JR, 1983)
"Micafungin was active against species of Candida and Aspergillus (even azole-resistant species) as well as Penicillium spp."1.35Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. ( Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL, 2009)
"5-flucytosine (5-FC) is an antifungal drug used for the treatment of serious infections caused by Candida or Cryptococcus spp."1.33Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. ( Bowker, KE; Lovering, AM; MacGowan, AP; Soltani, M; Sunderland, J; Tobin, CM, 2006)
"Posaconazole was the most active of antifungal agents tested against Aspergillus spp."1.33Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. ( Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL, 2006)
"Systemic fungal infections are rare."1.31Systemic phaeohyphomycosis in pregnancy and the puerperium. ( East-Innis, A; Fletcher, H; Nicholson, A; Phillip, H; Rainford, L; Williams, NP, 2000)
"Diagnosis and treatment of fungal infections in medical and surgical intensive care units are controversial issues."1.31[Fungal infections in intensive care units: a cross-survey]. ( Dupont, H, 2001)
"Yeast fungemia has increased markedly in the last few years."1.30[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]. ( Cuenca-Estrella, M; Rodríguez-Tudela, JL, 1999)
"Voriconazole was most active against P."1.30Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. ( Jones, RN; Marco, F; Messer, SA; Pfaller, MA, 1998)
" Lipid preparations of amphotericin B have reduced the toxicity of this agent, but some issues of dosage and efficacy remain."1.30Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy. ( , 1997)
"Amphotericin B was very active (MIC90 < or = 1."1.29In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. ( Barry, AL; Pfaller, MA, 1995)
"Miconazole, which was tested only with P."1.29Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. ( Gehrt, A; Peter, J; Pizzo, PA; Walsh, TJ, 1995)
" In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis."1.29Pharmacokinetics of antifungal agents. ( Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV, 1993)
"The results in histoplasmosis are encouraging, as are the results in chromomycosis, particularly those cases associated with Cladosporium carrionii."1.28Tropical mycoses. ( Bayles, MA, 1992)
"Fungal infections have become one of the major causes of death among immunocompromised patients, particularly patients with AIDS."1.28Treating systemic fungal infections in AIDS patients. Prolonging life against the odds. ( Scheld, WM, 1990)
" We also recommend an initial 24-hour dosing interval for amphotericin B and 5-fluorocytosine."1.28Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. ( Baley, JE; Blumer, JL; Jacobs, MR; Kliegman, RM; Meyers, C, 1990)
"Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained."1.28First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990)
"Fluconazole is a triazole antifungal compound with a very original distribution to the meninges and urinary tract; it is mainly used in candidiasis and cryptococcosis."1.28[Treatment of mycoses and new antifungal agents]. ( Dupont, B, 1989)
"Fusarium pathogen is an uncommon cause of infections in ophthalmology."1.28[Endophthalmitis due to Fusarium: an uncommon cause]. ( Berthe-Bonnet, S; Comhaire-Poutchinian, Y; Cremer, V; Grek, V, 1990)
" Although appropriate therapy of fungal peritonitis in patients undergoing CAPD still remains controversial, both for the drug of choice and for the dosage to be used, our study indicates that a 5-week course of oral 5-fluorocytosine (5-FC) may obviate the need to remove the peritoneal catheter during the management of peritonitis caused by susceptible strains of T glabrata."1.27Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine. ( Cecchin, E; Chiaradia, V; De Marchi, S; Franceschin, A; Panarello, G; Santini, G; Tesio, F, 1984)
" It is clearly seen from the table that the optimal modern therapy of systemic mycoses is a combination of 5-fluorocytosine in a normal dosage and amphotericin B at reduced dosage."1.27[Antimycotic chemotherapy in weakened resistance]. ( Wegmann, T, 1984)
"BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application."1.27Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984)
"Treatment with amphotericin B, 5-fluorocytosine, and splenectomy proved successful."1.27Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. ( Bhansali, S; Crane, L; Karanes, C; Kiel, R; Palutke, W; Ratanatharathorn, V, 1986)
"Multiple phaeohyphomycotic brain abscesses caused by Cladosporium species occurred in a 55 year old woman."1.27Cerebral phaeohyphomycosis. ( Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B, 1987)
"Miconazole was found to be an effective agent in some patients when administered in a dosage of 2400 mg/day."1.27Fungal endophthalmitis in narcotic abusers. Medical and surgical therapy in 10 patients. ( Billson, F; Clifton-Bligh, P; Gallo, J; Gregory-Roberts, J; Grunstein, H; Playfair, J, 1985)
"Ketoconazole was administered orally at daily dosages of 400-800 mg; 5-fluorocytosine was associated in four cases."1.27Ketoconazole: clinical evaluation in severe fungal infections. ( Arosio, E; Dean, P; Lechi, A; Montesi, G; Pancera, P, 1986)
"Our patient had a brain abscess and paranasal sinus infection due to C trichoides."1.26Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement. ( Brown, JW; Nadell, J; Sanders, CV; Sardenga, L, 1976)
"Three cases, one of mycetoma, one of chromomycosis, one of histoplasmosis, are described."1.26Mycoses imported from the West Indies. A report of three cases. ( Hay, RJ, 1979)
" In three patients, accumulation of toxic levels of 5-FC was related to diminished renal function."1.26Bone marrow toxicity associated with 5-fluorocytosine therapy. ( Frame, PT; Kauffman, CA, 1977)

Research

Studies (289)

TimeframeStudies, this research(%)All Research%
pre-1990166 (57.44)18.7374
1990's75 (25.95)18.2507
2000's39 (13.49)29.6817
2010's8 (2.77)24.3611
2020's1 (0.35)2.80

Authors

AuthorsStudies
Serena, C1
Rodríguez, MM1
Mariné, M2
Pastor, FJ2
Guarro, J4
Cuenca-Estrella, M7
Gomez-Lopez, A4
Gutierrez, MO1
Buitrago, MJ3
Rodriguez-Tudela, JL5
Mellado, E2
Monzon, A2
Kathiravan, MK1
Salake, AB1
Chothe, AS1
Dudhe, PB1
Watode, RP1
Mukta, MS1
Gadhwe, S1
Johnson, MD1
Chiron, LM1
Pihet, M1
Rouleau, F1
de Gentile, L1
Bouchara, JP1
Chabasse, D1
Lepak, AJ1
Andes, DR1
Delarze, E1
Sanglard, D2
Narendran, N1
Balasubramaniam, B1
Johnson, E1
Dick, A1
Mayer, E1
Tarumoto, N1
Maesaki, S2
Araujo Ribeiro, M1
Alastruey-Izquierdo, A1
Pemán, J1
Cantón, E1
Espinel-Ingroff, A2
Ruiz-Camps, I1
Houbraken, J1
Verweij, PE1
Rijs, AJ1
Borman, AM1
Samson, RA1
Jullien, V1
Kontoyiannis, DP1
Clerihew, L1
McGuire, W1
Silverberg, D1
Kodali, P1
Dipersio, J1
Acus, R1
Askew, M1
Olver, WJ1
James, SA1
Lennard, A1
Galloway, A1
Roberts, IN1
Boswell, TC1
Russell, NH1
Loeffler, J1
Stevens, DA2
Polak, A4
Groll, AH1
Gea-Banacloche, JC1
Glasmacher, A2
Just-Nuebling, G1
Maschmeyer, G1
Walsh, TJ9
Fehér, J1
Lengyel, G1
Negroni, R2
Helou, SH1
Petri, N1
Robles, AM1
Arechavala, A1
Bianchi, MH1
Komatsu, M1
Aihara, M1
Shimakawa, K1
Iwasaki, M1
Nagasaka, Y1
Fukuda, S1
Abe, N1
Matsuo, S1
Ozçelik, B1
Citak, S1
Cesur, S1
Abbasoğlu, U1
Içli, F1
Steinbach, WJ2
Zaoutis, TE1
Benjamin, DK1
Herbrecht, R1
Nivoix, Y1
Fohrer, C1
Natarajan-Amé, S1
Letscher-Bru, V1
Braun, JJ1
Pauli, G1
de Blay, F1
Burkert, M1
Fuhr, HG1
Mertelsmann, R1
Kendirli, T1
Ciftçi, E1
Ince, E1
Oncel, S1
Dalgiç, N1
Güriz, H1
Unal, E1
Dogru, U1
Soltani, M1
Tobin, CM1
Bowker, KE1
Sunderland, J1
MacGowan, AP1
Lovering, AM1
Makimura, K1
Hara, S1
Yokote, T1
Oka, S1
Akioka, T1
Kobayashi, K1
Hirata, Y1
Miyoshi, T1
Tsuji, M1
Hanafusa, T1
Chen, SC1
Sorrell, TC1
Goodwin, ML1
Drew, RH1
Smith, J1
Andes, D1
Lefrock, JL1
Smith, BR1
Padhye, AA2
Kaplan, W1
Neuman, MA1
Case, P1
Radcliffe, GN1
Takeuchi, H2
Arai, Y1
Konami, T1
Ikeda, T1
Tomoyoshi, T2
Tatewaki, K1
Seaworth, BJ1
Kwon-Chung, KJ2
Hamilton, JD2
Perfect, JR1
Arai, T2
Roberts, DT1
Höffken, G1
Lode, H1
Graybill, JR3
Craven, PC1
Brabender, W1
Hodges, GR1
Stamm, AM1
Dismukes, WE1
Medoff, G6
Brajtburg, J1
Kobayashi, GS5
Bolard, J1
Plempel, M3
Rusthoven, JJ1
Feld, R1
Tuffnell, PG1
Koldin, MH1
Hermans, PE2
Keys, TF1
Uno, H1
Clemente González, C1
Kostiala, AA1
Kostiala, I1
Kambayashi, J1
Ogawa, Y1
Kosaki, G1
Bossa, R1
Galatulas, I1
Wegmann, T5
Cecchin, E3
Panarello, G3
De Marchi, S3
Droller, DD1
Franceschin, A1
Chiaradia, V2
Santini, G1
Tesio, F3
Korinek, JK1
Guarda, LA1
Bolivar, R1
Stroehlein, JR1
Oelz, O2
Schaffner, A1
Frick, P1
Schaer, G1
Gross, M1
Baley, JE2
Kliegman, RM2
Fanaroff, AA1
Hay, RJ2
Kaell, AT1
Weitzman, I2
Qadripur, SA1
Yoshikawa, TT1
Holt, RJ2
Bell, WE1
Utz, JP7
Wilson, E1
Watanakunakorn, C1
Roselle, GA1
Dupont, B6
Drouhet, E2
Pizzo, PA2
László, A1
Ikemoto, H3
Riyat, MS1
Vazzana, A1
Sandven, P2
Rohner, TJ1
Tuliszewski, RM1
Corrado, ML1
Stanek, A1
Goetz, R1
Agyare, E1
Lee, SH2
Chiang, SS2
Hseih, SJ2
Shen, HM2
Gehrt, A1
Peter, J1
Pfaller, MA2
Barry, AL1
Vanden Bossche, H1
Warnock, DW1
Kerridge, D2
Sen Gupta, S1
Improvisi, L1
Marichal, P1
Odds, FC1
Provost, F1
Ronin, O1
Viviani, MA1
Naito, K1
Murate, T1
Hotta, T1
Saito, H1
Hamajima, N1
Naoe, T1
Ogura, M1
Ariyoshi, H1
Tanaka, M1
Kodera, Y1
Pogliani, E1
Clini, E1
Amici, G1
Grandesso, S1
Mottola, A1
Virga, G1
Teodori, T1
Maresca, MC1
Bocci, C1
Lynch, ME1
Sobel, JD1
Björkholm, M1
Bickers, DR1
Michel, C1
Courdavault, L1
al Khayat, R1
Viron, B1
Roux, P1
Mignon, F1
Yamaguchi, H1
Uchida, K1
Palaoglu, S1
Sav, A1
Basak, T1
Yalcinlar, Y1
Scheithauer, BW1
Supparatpinyo, K1
Nelson, KE1
Merz, WG2
Breslin, BJ1
Cooper, CR1
Kamwan, C1
Sirisanthana, T1
Aoba, S1
Komiyama, A1
Hasegawa, O1
Fabris, A1
Pellanda, MV1
Gardin, C1
Contestabile, A1
Bolzonella, R1
Lyman, CA2
Guiserix, J1
Ramdane, M1
Finielz, P1
Michault, A1
Rajaonarivelo, P1
Chanock, SJ1
Kubo, N1
Hiramitsu, S1
Morimoto, S1
Hood, SV1
Moore, CB1
Cheesbrough, JS1
Mene, A1
Denning, DW1
Tiballi, RN1
Spiegel, JE1
Zarins, LT1
Kauffman, CA2
Berenguer Berenguer, J1
Summers, KK1
Hardin, TC1
Gore, SJ1
Just-Nübling, G1
Molitor, E1
Rex, JH1
Anaissie, EJ1
Andriole, VT1
Watanabe, K2
Marco, F1
Messer, SA1
Jones, RN1
Pujol, I1
Mayayo, E1
de Pauw, BE2
Meunier, F1
Hossain, MA1
Sasaki, E1
Hashiguchi, K1
Higashiyama, Y1
Yoshitsugu, Y1
Tomono, K1
Tashiro, T1
Kohno, S1
Kullberg, BJ1
Marwaha, RK1
Maheshwari, A1
Fletcher, H1
Williams, NP1
Nicholson, A1
Rainford, L1
Phillip, H1
East-Innis, A1
Cawley, MJ1
Braxton, GR1
Haith, LR1
Reilly, KJ1
Guilday, RE1
Patton, ML1
Rimek, D1
Zimmermann, T1
Hartmann, M1
Prariyachatigul, C1
Kappe, R1
Silling, G1
Fegeler, W1
Roos, N2
Essink, M1
Büchner, T2
Vermes, A1
Guchelaar, HJ1
Dankert, J1
Lieberman, TW1
Leopold, IH1
Aoun, M1
Llop, C1
Sala, J1
Riba, MD1
André, MH1
Lortholary, O1
Dupont, H1
Rivera, R1
Cangir, A1
Tan, RJ1
Lim, EW1
Ishak, B1
Hecht, R1
Montgomerie, JZ1
Codish, SD2
Sheridan, ID1
Monaco, AP2
Jones, DB1
Rowsey, JJ1
Acers, TE1
Smith, DL1
Mohr, JA1
Newsom, DL1
Rodriguez, J1
Bennet, JE1
Ashe, WD1
Van Reken, DE1
Ata, H1
Hoeprich, PD1
Tobias, JS1
Norrby, R2
Eilard, T2
Baum, GL1
Coodley, EL1
Lapresle, C1
Wain, W1
Ahmed, M1
Thompson, R1
Yacoub, M1
Muther, RS1
Bennett, WM1
Block, CS1
Young, CN1
Myers, RA1
Kraatz, G1
Bernhardt, H1
Ranft, R1
Aurich, G4
Plenert, W3
Male, O1
Bergan, T1
Krick, JA2
Remington, JS2
Beskow, D1
Wåhlén, P1
Alestig, K1
Michigan, S1
Frame, PT1
Hofstetter, A1
Schönebeck, J1
Middleton, FG1
Jurgenson, PF1
Shadomy, S2
Shadomy, HJ1
Lutwick, LI1
Galgiani, JN1
Johnson, RH1
Feuerstein, M1
Plennert, W1
Zintl, F1
Brown, JW1
Nadell, J1
Sanders, CV1
Sardenga, L1
Gallis, HA1
Berman, RA1
Cate, TR1
Gunnells, JC1
Stickel, DL1
Salit, I1
Hand, R1
Drevets, CC1
Hummer, LM1
Rubinstein, E1
Noriega, ER1
Simberkoff, MS1
Holzman, R1
Rahal, JJ1
Meinhof, W1
Würsten, D1
Bayles, MA1
Van Cutsem, J1
Kujala, P1
Ruutu, P1
Sekhon, AS2
Galbraith, J1
Mielke, BW1
Garg, AK1
Sheehan, G1
Naidu, J1
Singh, SM1
Sudduth, EJ1
Crumbley, AJ1
Farrar, WE1
Tokunaga, S1
Ohkawa, M1
Nakashima, T1
Yamaguchi, K1
Nishikawa, T1
Matsushita, T1
Mikawa, I1
Hirano, S1
Kawaguchi, S1
Miyagi, T1
Francis, P1
Terrell, CL2
Hughes, CE1
Nielsen, H1
Stenderup, J1
Bruun, B1
Sides, EH1
Benson, JD1
Fujihiro, S1
Ehara, H1
Saito, A1
Ito, Y1
Kanematu, M1
Ban, Y1
Kawada, Y1
Koppang, HS1
Olsen, I1
Stuge, U1
Comhaire-Poutchinian, Y1
Berthe-Bonnet, S1
Grek, V1
Cremer, V1
Wolf, HH1
Scharf, RE1
Arning, M1
Schneider, W1
Scheld, WM1
Schinella, D1
Pascoli, L1
Santini, GF1
Meyers, C1
Jacobs, MR1
Blumer, JL1
Surmont, I1
Vergauwen, B1
Marcelis, L1
Verbist, L1
Verhoef, G1
Boogaerts, M1
Ogata, K1
Tanabe, Y1
Iwakiri, K1
Ito, T1
Yamada, T1
Dan, K1
Nomura, T1
Mitchell, DM1
Fitz-Henley, M1
Horner-Bryce, J1
Ette, A1
Bamba, M1
Adjoua, P1
Boguifo, J1
Ette, EE1
Fakhry, K1
Therizol, MF1
Guarner, J1
Del Rio, C1
Williams, P1
McGowan, JE1
Mocan, H1
Murphy, AV1
Beattie, TJ1
McAllister, TA1
Pizzo, A1
Murphy, N1
Buchanan, CR1
Damjanovic, V1
Whitaker, R1
Hart, CA1
Cooke, RW1
Zimmermann-Hölsi, MB1
Stahel, RA1
Vogt, P1
Karp, JE1
Hoagland, M1
Jett-Goheen, M1
Junkins, JM1
Hood, AF1
Tang, LM1
Ryu, SJ1
Chen, TJ1
Cheng, SY1
Mina, FA1
Hopkins, SJ1
Richelo, B1
Bodey, GP1
Donald, FE1
Sharp, JF1
Firth, JL1
Crowley, JL1
Ispahani, P1
van 't Wout, JW1
van Furth, R1
Bhansali, S1
Karanes, C1
Palutke, W1
Crane, L1
Kiel, R1
Ratanatharathorn, V1
Meyer, RD1
Washida, H1
Tsugaya, M1
Hirao, N1
Sakagami, H1
Iwase, Y1
Abu Aisha, H1
Laajam, M1
Yaqoub, B1
Chagla, AH1
Tapson, JS1
Mansy, H1
Freeman, R1
Wilkinson, R1
Edwards, R1
Birrell, LN1
Finch, RG1
Gallo, J1
Playfair, J1
Gregory-Roberts, J1
Grunstein, H1
Clifton-Bligh, P1
Billson, F1
Yang, DJ1
Rankin, GO1
Lechi, A1
Montesi, G1
Dean, P1
Pancera, P1
Arosio, E1
Johnson, RJ1
Ramsey, PG1
Gallagher, N1
Ahmad, S1
Benevent, D1
Peyronnet, P1
Lagarde, C1
Leroux-Robert, C1
Willans, DJ1
Harvey, JH1
O'Grady, F1
Clayton, YM1
Riley, HD2
Reznikova, MM1
Agarunova, IuS1
Harford, CG1
Brunner, J1
Engeler, V1
Firkin, FC1
Newberry, WM1
Smith, JW1
Abernathy, RS1
Bennett, JE3
Block, ER2
Jennings, AE1
Fishbach, RS1
White, ML1
Finegold, SM1
Livoti, LG1
Klein, WJ1
MacGregor, RR1
Henderson, L1

Reviews

95 reviews available for flucytosine and Mycoses

ArticleYear
The biology and chemistry of antifungal agents: a review.
    Bioorganic & medicinal chemistry, 2012, Oct-01, Volume: 20, Issue:19

    Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses

2012
Antifungals in Clinical Use and the Pipeline.
    Infectious disease clinics of North America, 2021, Volume: 35, Issue:2

    Topics: Antifungal Agents; Azoles; Drugs, Investigational; Echinocandins; Flucytosine; Humans; Mycoses; Poly

2021
Antifungal pharmacokinetics and pharmacodynamics.
    Cold Spring Harbor perspectives in medicine, 2014, Nov-10, Volume: 5, Issue:5

    Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycose

2014
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2015, Volume: 23

    Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug T

2015
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucyt

2008
Antifungal drug resistance mechanisms.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:4

    Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Flucytosine

2009
[Antifungals for systemic use].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:6

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Drug Therapy, Combination; Drugs, Investigationa

2009
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Human

2011
Invasive mycoses: strategies for effective management.
    The American journal of medicine, 2012, Volume: 125, Issue:1 Suppl

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Asparta

2012
Antifungal therapy for newborn infants with invasive fungal infection.
    The Cochrane database of systematic reviews, 2012, Jun-13, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Infant, Newborn; Infant, Premat

2012
Clinical relevance of mechanisms of antifungal drug resistance in yeasts.
    Enfermedades infecciosas y microbiologia clinica, 2002, Volume: 20, Issue:9

    Topics: Antifungal Agents; Azoles; Biological Transport; Candidiasis; Drug Resistance, Fungal; Drug Utilizat

2002
[Flucytosine - a classical partner for combination therapy].
    Mycoses, 2002, Volume: 45 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Mitosporic Fungi;

2002
Clinical pharmacology of antifungal compounds.
    Infectious disease clinics of North America, 2003, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins;

2003
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Orvosi hetilap, 2003, Aug-24, Volume: 144, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole

2003
Combinations of antifungal agents in therapy--what value are they?
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Caspofungin; Drug Therapy, Combination; Echinoca

2004
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutica

2005
Antifungal treatment in pediatric patients.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Re

2005
Management of systemic fungal infections: alternatives to itraconazole.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Top

2005
[Mechanisms of resistance to antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Fungal; Flucytosine; Fungi; Humans; Myco

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucyto

2007
Antifungal serum concentration monitoring: an update.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:1

    Topics: Antifungal Agents; Azoles; Echinocandins; Flucytosine; Humans; Monitoring, Physiologic; Mycoses

2008
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimid

2008
[Action mechanism and resistance of drugs used in visceral mycoses].
    Nihon rinsho. Japanese journal of clinical medicine, 1980, Volume: 38, Issue:11

    Topics: Animals; Antifungal Agents; Candida albicans; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resi

1980
The current status of systemic antifungal agents.
    The British journal of dermatology, 1982, Volume: 106, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Mico

1982
[Systemic antimycotic treatment].
    Deutsche medizinische Wochenschrift (1946), 1982, Sep-24, Volume: 107, Issue:38

    Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; K

1982
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
    Drugs, 1983, Volume: 25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketocona

1983
Current therapy of pulmonary and disseminated fungal diseases.
    Chest, 1983, Volume: 83, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C

1983
Antifungal agents useful in therapy of systemic fungal infections.
    Annual review of pharmacology and toxicology, 1983, Volume: 23

    Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosi

1983
Antifungal chemotherapy.
    Pediatric clinics of North America, 1983, Volume: 30, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Flucytosine; Humans;

1983
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1983, Volume: 58, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Flucytosine; Humans; Imidazoles; Myc

1983
[Basis of antifungal chemotherapy].
    Nihon saikingaku zasshi. Japanese journal of bacteriology, 1983, Volume: 38, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Drug Ther

1983
[Current treatment of systematic mycoses].
    Medicina clinica, 1983, Oct-29, Volume: 81, Issue:13

    Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine;

1983
[Antifungal agents].
    La Clinica terapeutica, 1981, Oct-15, Volume: 99, Issue:1

    Topics: Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Mycoses; Phenyl Ethers; Polyenes;

1981
Strategies in the treatment of systemic fungal infections.
    The New England journal of medicine, 1980, Jan-17, Volume: 302, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Microbial; Drug Therapy,

1980
Progress in antimycotic chemotherapy 1945-1980.
    Infection, 1980, Volume: 8 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis; Flucytosine; Humans; Imidazoles; Myco

1980
Treatment of fungal infections of the central nervous system.
    Annals of neurology, 1981, Volume: 9, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Chemical Phenomena; Chemistry; F

1981
Chemotherapy of the systemic mycoses.
    The Medical clinics of North America, 1982, Volume: 66, Issue:1

    Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Mycoses; Potassium Iodide; Stilbamidines

1982
Mechanisms and clinical impact of antifungal drug resistance.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1994, Volume: 32 Suppl 1

    Topics: Amphotericin B; Azoles; Drug Resistance, Microbial; Flucytosine; Fungi; Humans; Mycoses; Treatment F

1994
Flucytosine--what is its future?
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:2

    Topics: Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Forecasting; Hum

1995
Chemoprophylaxis of fungal infections in neutropenic patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles

1994
Antifungal therapy: potential interactions with other classes of drugs.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Flu

1994
Fungal peritonitis in patients on peritoneal dialysis.
    American journal of nephrology, 1994, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ

1994
Treatment of systemic mycoses in patients with AIDS.
    Archives of medical research, 1993,Winter, Volume: 24, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Flucytosine; Humans; Mycoses; Poly

1993
Cerebral phaeohyphomycosis.
    Neurosurgery, 1993, Volume: 33, Issue:5

    Topics: Adolescent; Biopsy; Brain Abscess; Cerebral Arteries; Cladosporium; Combined Modality Therapy; Crani

1993
New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases.
    Cancer treatment and research, 1995, Volume: 79

    Topics: Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; Immunocompromised Host; Mycoses; Neo

1995
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Flu

1996
[Fungal myocarditis].
    Ryoikibetsu shokogun shirizu, 1996, Issue:14

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Flucytosine; Humans; Mycoses; Myocarditis; Prognosis

1996
Clinical relevance of antifungal resistance.
    Infectious disease clinics of North America, 1997, Volume: 11, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial;

1997
[Commonly used antifungal agents in the treatment of systemic mycoses].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top

1995
Therapeutic drug monitoring of systemic antifungal therapy.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Drug Monitoring; Flucytosine; Humans; Itraconazole; Mycoses

1997
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
    Deutsche medizinische Wochenschrift (1946), 1998, Feb-13, Volume: 123, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazol

1998
Fungal infections in iatrogenically compromised hosts.
    Advances in internal medicine, 1998, Volume: 43

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Catheters, Indwelling; Diagno

1998
Current and future therapy of invasive fungal infections.
    Current clinical topics in infectious diseases, 1998, Volume: 18

    Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles

1998
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Nov-10, Volume: 87, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycos

1998
The challenge of invasive fungal infection.
    Chemotherapy, 1999, Volume: 45 Suppl 1

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis

1999
[The future of antifungal agents. Non azole antifungal agents].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 1999, Volume: 40, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Carriers; Echinocandins; Flucytosine; Fungi; Glucos

1999
Therapy of invasive fungal infections.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy,

1999
Systemic antifungal therapy in pediatric practice.
    Indian pediatrics, 1999, Volume: 36, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Child; Flucytosine; Griseofulvin; Humans; In

1999
Trichosporon beigelii infection: experience in a regional burn center.
    Burns : journal of the International Society for Burn Injuries, 2000, Volume: 26, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial;

2000
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: Animals; Antifungal Agents; Drug Interactions; Flucytosine; Fungi; Humans; Mycoses

2000
New antifungal therapy in ophthalmology.
    Transactions of the American Ophthalmological Society, 1973, Volume: 71

    Topics: Antifungal Agents; Candidiasis; Clotrimazole; Eye Diseases; Flucytosine; Humans; Immunotherapy; Myco

1973
Standard antifungal therapy in neutropenic patients.
    International journal of antimicrobial agents, 2000, Volume: 16, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fever; Flucytosine; Humans; Mycoses; Neutropenia

2000
[Choice and use of antifungal drugs].
    La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itr

2001
Flucytosine.
    Annals of internal medicine, 1977, Volume: 86, Issue:3

    Topics: Amphotericin B; Candidiasis; Chromoblastomycosis; Cryptococcosis; Cytosine; Drug Therapy, Combinatio

1977
5-fluorocytosine: a brief review.
    Clinical pediatrics, 1977, Volume: 16, Issue:4

    Topics: Candidiasis; Cytosine; Drug Resistance; Drug Therapy, Combination; Flucytosine; Humans; Mycoses

1977
Antifungal agents: recent developments.
    Annual review of microbiology, 1977, Volume: 31

    Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Chemical Phenomena; Chemistry; Clotrimazole; Drug

1977
Chemotherapy of systemic fungal diseases.
    Annual review of pharmacology and toxicology, 1978, Volume: 18

    Topics: Amphotericin B; Animals; Eukaryota; Flucytosine; Helminths; Humans; Miconazole; Mycoplasma; Mycoses;

1978
[Progress in the therapy of systemic mycoses].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1978, Issue:84

    Topics: Amphotericin B; Aspergillus; Candida; Clotrimazole; Cryptococcus; Drug Therapy, Combination; Flucyto

1978
Treatment of opportunistic systemic mycoses.
    Scandinavian journal of infectious diseases. Supplementum, 1978, Issue:16

    Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Fl

1978
Opportunistic invasive fungal infections in patients with leukaemia lymphoma.
    Clinics in haematology, 1976, Volume: 5, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Amphotericin B; Aspergillosis; Blood Transfusion; Candidiasi

1976
Genitourinary fungal infections.
    The Journal of urology, 1976, Volume: 116, Issue:4

    Topics: Amphotericin B; Animals; Candida; Candidiasis; Female; Flucytosine; Genital Diseases, Female; Genita

1976
Antifungal treatment strategy in leukemia patients.
    Annals of hematology, 1992, Volume: 65, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itra

1992
[Systemic antifungal drugs].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole;

1991
Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Drugs, 1992, Volume: 44, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Resistance, Microbial; Drugs, Investigational; Flucy

1992
Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antibodies, Fungal; Brain Abscess; Child; Cladosporium; Fem

1992
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:4

    Topics: Adult; Amphotericin B; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combin

1992
Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Amphotericin B; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine;

1992
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
    Lancet (London, England), 1991, Jun-29, Volume: 337, Issue:8757

    Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Dru

1991
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1992, Volume: 67, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase;

1992
Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics.
    Scandinavian journal of infectious diseases, 1991, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Child; Ch

1991
Combination therapy in systemic mycosis.
    Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:4

    Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio

1990
[The antimycotic drugs].
    Der Internist, 1989, Volume: 30, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses

1989
Fungal peritonitis caused by Curvularia lunata in a patient undergoing peritoneal dialysis.
    The American journal of the medical sciences, 1989, Volume: 298, Issue:5

    Topics: Bacterial Infections; Catheters, Indwelling; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fung

1989
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; D

1987
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans;

1988
Diagnosis and successful treatment of fusariosis in the compromised host.
    The Journal of infectious diseases, 1988, Volume: 158, Issue:5

    Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia,

1988
Topical and systemic antifungal agents.
    The Medical clinics of North America, 1988, Volume: 72, Issue:3

    Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ket

1988
Cutaneous and mucosal manifestations of the deep mycotic infections.
    Acta dermato-venereologica. Supplementum, 1986, Volume: 121

    Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi

1986
Mode of action of clinically important antifungal drugs.
    Advances in microbial physiology, 1986, Volume: 27

    Topics: Allylamine; Antifungal Agents; Candida albicans; Cell Membrane; Cell Nucleus; Cell Wall; Dermatomyco

1986
Nephrotoxicity of antifungal agents.
    Adverse drug reactions and acute poisoning reviews, 1985,Spring, Volume: 4, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Flucytosine; Grise

1985
Pharmacokinetics of the treatment of fungal infections.
    Journal of the Royal College of Physicians of London, 1972, Volume: 7, Issue:1

    Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Aspergillus; Benzene Derivatives; Candida; Derm

1972
Therapy of fungal infections.
    The British journal of dermatology, 1973, Volume: 89, Issue:4

    Topics: Administration, Topical; Amphotericin B; Candidiasis; Coccidioides; Flucytosine; Fusarium; Griseoful

1973
Therapy with amphotericin B and other new antifungal agents.
    The Journal of the Oklahoma State Medical Association, 1974, Volume: 67, Issue:4

    Topics: Alkenes; Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; Injections, Intravenous; M

1974
[Chemotherapy of deep mycoses (a review of the literature)].
    Vestnik dermatologii i venerologii, 1973, Volume: 47, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Chronic Disease; Flucytosine; Humans; Imidazoles; Mycoses; Natamy

1973
Drug treatment of the systemic mycoses.
    Seminars in drug treatment, 1972,Winter, Volume: 2, Issue:3

    Topics: Actinomycosis; Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidi

1972

Trials

6 trials available for flucytosine and Mycoses

ArticleYear
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Glucans

1994
Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
    Mycoses, 1999, Volume: 42 Suppl 2

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fluco

1999
Antifungal therapy, 1978.
    Postgraduate medical journal, 1979, Volume: 55, Issue:647

    Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clinical Trials as Topic; Flucytosine; History, 18

1979
[Flucytosine in the treatment of urinary fungal infections. Clinical efficacy and background factors].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Candida; Female; Flucytosine; Humans; Immune Tolerance; Male; Middle

1991
Combination therapy in systemic mycosis.
    Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:4

    Topics: Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combinatio

1990
[5-Flour-ocytosin as treatment agent in genital mycosis (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1974, Dec-03, Volume: 63, Issue:48

    Topics: Candida albicans; Cytosine; Drug Evaluation; Female; Flucytosine; Humans; Mycoses; Nystatin; Vaginal

1974

Other Studies

189 other studies available for flucytosine and Mycoses

ArticleYear
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Sy

2007
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; H

2008
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi;

2009
[Comment on this case report].
    Journal de mycologie medicale, 2012, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Buprenorphine; Candidiasis; Endocarditis; Endophthalmitis;

2012
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infecti

2008
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal;

2008
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combin

2009
Identification of Paecilomyces variotii in clinical samples and settings.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine;

2010
In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
    Clinical orthopaedics and related research, 2002, Issue:403

    Topics: Amphotericin B; Antifungal Agents; Arthroplasty, Replacement; Bone Cements; Candida; Colony Count, M

2002
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients.
    The Journal of hospital infection, 2002, Volume: 52, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Carrier State; Cross Infectio

2002
Antifungal drug resistance.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jan-15, Volume: 36, Issue:Suppl 1

    Topics: Antifungal Agents; Azoles; Biological Transport; DNA-Binding Proteins; Drug Resistance, Microbial; E

2003
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itracon

2004
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandi

2003
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
    Drug metabolism and drug interactions, 2004, Volume: 20, Issue:1-2

    Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans

2004
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
    Revue des maladies respiratoires, 2005, Volume: 22, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality T

2005
Antimycotic combination therapy in patients with acute myeloblastic leukemia.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Administration Schedule; Drug Thera

1989
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Huma

2006
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
    Mycoses, 2006, Volume: 49, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Male;

2006
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:6

    Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Flucytosine; Humans; Infant; Infant, Ne

2006
Endophthalmitis due to Trichosporon beigelii in acute leukemia.
    International journal of hematology, 2007, Volume: 85, Issue:5

    Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; F

2007
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
    Sabouraudia, 1984, Volume: 22, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combinat

1984
Effective systemic antifungal agents.
    American family physician, 1984, Volume: 30, Issue:6

    Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucyto

1984
Subcutaneous phaeohyphomycosis caused by Exophiala spinifera.
    Sabouraudia, 1984, Volume: 22, Issue:6

    Topics: Flucytosine; Humans; Ketoconazole; Middle Aged; Mitosporic Fungi; Mycoses; Skin; Species Specificity

1984
[A study on urinary fungal infection].
    Hinyokika kiyo. Acta urologica Japonica, 1983, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Bicarbonates; Candida; Candidiasis;

1983
Brain abscess caused by a variety of cladosporium trichoides.
    American journal of clinical pathology, 1983, Volume: 79, Issue:6

    Topics: Amphotericin B; Brain Abscess; Cladosporium; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fung

1983
Drugs for treatments of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1982, Apr-02, Volume: 24, Issue:606

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose

1982
Antimicrobial treatment of systemic fungal infections.
    The Journal of the Kansas Medical Society, 1983, Volume: 84, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose

1983
Drugs for treatment of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1984, Mar-30, Volume: 26, Issue:658

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Mic

1984
Antimycotic activity of BAY N 7133 in animal experiments.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill

1984
Systemic infection by Rhodotorula spp. in the immunocompromised host.
    The Journal of infection, 1984, Volume: 8, Issue:3

    Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liv

1984
Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies.
    Journal of medical microbiology, 1984, Volume: 18, Issue:2

    Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Flucyto

1984
[Fungal sepsis and DIC in surgical patients].
    Nihon Geka Gakkai zasshi, 1983, Volume: 84, Issue:9

    Topics: Adult; Aged; Amphotericin B; Disseminated Intravascular Coagulation; Female; Flucytosine; Gabexate;

1983
[Antimycotic chemotherapy in weakened resistance].
    Immunitat und Infektion, 1984, Volume: 12, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Azo Compounds; Disease Susceptibility; Flucytosine; Humans; Immun

1984
Fungal peritonitis in ambulatory peritoneal dialysis.
    Annals of internal medicine, 1984, Volume: 100, Issue:2

    Topics: Candida; Candidiasis; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis, Contin

1984
Infection of the olecranon bursa by Anthopsis deltoidea.
    Journal of clinical microbiology, 1984, Volume: 20, Issue:2

    Topics: Aged; Bursa, Synovial; Bursitis; Combined Modality Therapy; Elbow Joint; Flucytosine; Humans; Male;

1984
Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1984, Volume: 4, Issue:3

    Topics: Aged; Candida; Female; Flucytosine; Humans; Male; Mycoses; Peritoneal Dialysis; Peritoneal Dialysis,

1984
Trichosporon hepatitis.
    Gastroenterology, 1983, Volume: 85, Issue:3

    Topics: Adult; Amphotericin B; Aspergillosis; Biopsy; Female; Flucytosine; Hepatitis; Humans; Leukemia, Myel

1983
Trichosporon capitatum: thrush-like oral infection, local invasion, fungaemia and metastatic abscess formation in a leukaemic patient.
    The Journal of infection, 1983, Volume: 6, Issue:2

    Topics: Abscess; Adult; Amphotericin B; Blood; Female; Flucytosine; Humans; Leukemia, Myeloid, Acute; Mitosp

1983
Drug therapy of systemic fungal infections, Part II.
    North Carolina medical journal, 1984, Volume: 45, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses

1984
Torulopsis infection extensively involving urinary tract.
    Urology, 1983, Volume: 22, Issue:2

    Topics: Amphotericin B; Biopsy; Candida; Flucytosine; Humans; Male; Middle Aged; Mycoses; Therapeutic Irriga

1983
Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity.
    Pediatrics, 1984, Volume: 73, Issue:2

    Topics: Acute Kidney Injury; Amphotericin B; Cytosine; Flucytosine; Humans; Infant; Infant, Low Birth Weight

1984
Managing fungal infections.
    British journal of hospital medicine, 1984, Volume: 31, Issue:4

    Topics: Anti-Infective Agents, Local; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Imidazoles; Im

1984
Acute monoarticular arthritis due to Phialophora parasitica.
    The American journal of medicine, 1983, Volume: 74, Issue:3

    Topics: Arthritis, Infectious; Biopsy, Needle; Flucytosine; Humans; Knee Joint; Male; Middle Aged; Mycoses;

1983
[Antimycotic therapy. 1: Classification, antimycotic drugs: flucytosine, tolnaftate].
    Fortschritte der Medizin, 1983, Feb-24, Volume: 101, Issue:8

    Topics: Antifungal Agents; Cytosine; Flucytosine; Humans; Mycoses; Tolnaftate

1983
Drugs for fungal infections.
    American family physician, 1980, Volume: 22, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Child; Flucytosine; Griseofulvin; Humans; Miconazole; Myco

1980
Cerebral abscess caused by Cladosporium bantianum. Case report.
    Pathology, 1982, Volume: 14, Issue:1

    Topics: Amphotericin B; Brain Abscess; Cladosporium; Female; Flucytosine; Humans; Hydrocephalus; Microbiolog

1982
Treatment of systemic fungus infections.
    Comprehensive therapy, 1982, Volume: 8, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Miconazole; Mycoses

1982
The measurement of serum 5-fluorocytosine levels in the presence of miconazole.
    American journal of clinical pathology, 1982, Volume: 78, Issue:3

    Topics: Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Miconazole; Mycoses

1982
[Antifungal agents in otorhinolaryngology].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 1982, Volume: 99, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos

1982
Infectious complications in the child with cancer. II. Management of specific infectious organisms.
    The Journal of pediatrics, 1981, Volume: 98, Issue:4

    Topics: Amphotericin B; Bacterial Infections; Child; Flucytosine; Humans; Infections; Mycoses; Neoplasms; Pr

1981
[Therapy of systemic mycoses].
    Orvosi hetilap, 1981, Jan-04, Volume: 122, Issue:1

    Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Polyenes

1981
[Management of visceral mycoses, with special reference to drug therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 1980, Volume: 38, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Flucytosine; Humans; Lung Diseases, F

1980
[Present status and future prospect in the studies of antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1981, Volume: 39, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Flucytosine; Humans; Imidazoles; Mycoses

1981
[New pharmaceuticals in systemic mycoses (author's transl)].
    Zeitschrift fur Hautkrankheiten, 1981, Sep-01, Volume: 56, Issue:17

    Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; D

1981
Practical therapeutics chemotherapy of fungal infections.
    East African medical journal, 1981, Volume: 58, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Drug Evaluation; Flucytosine; Griseofulvin; Humans; Mycoses

1981
[Microbial sensitivity tests with antifungal agents and their determination in body fluids].
    Quaderni Sclavo di diagnostica clinica e di laboratorio, 1981, Volume: 17, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Microbial Sensitivity Tests; Mycoses

1981
[Treatment of systemic mycoses].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1981, Sep-30, Volume: 101, Issue:27

    Topics: Amphotericin B; Cytosine; Flucytosine; Humans; Mycoses

1981
Treating fungal infections.
    British medical journal, 1980, Mar-08, Volume: 280, Issue:6215

    Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses

1980
Fungal cystitis: awareness, diagnosis and treatment.
    The Journal of urology, 1980, Volume: 124, Issue:1

    Topics: Amphotericin B; Candidiasis; Cystitis; Female; Flucytosine; Humans; Male; Middle Aged; Mycoses

1980
Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
    Sabouraudia, 1980, Volume: 18, Issue:2

    Topics: Adult; Aged; Amphotericin B; Cycloheximide; Cytosine; Drug Resistance, Microbial; Flucytosine; Human

1980
Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1995, Volume: 94, Issue:3

    Topics: Administration, Oral; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Fluc

1995
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Colony Count, Microbia

1995
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Mycopathologia, 1995, Volume: 130, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Flucytosi

1995
Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:6

    Topics: Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Cryptoc

1994
Verticillium peritonitis in a patient on peritoneal dialysis.
    American journal of nephrology, 1994, Volume: 14, Issue:3

    Topics: Adult; Fluconazole; Flucytosine; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Conti

1994
Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1994, Volume: 32, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis, Vulvovaginal; Fem

1994
[In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:8

    Topics: Amphotericin B; Aspergillus; Candida; Child; Drug Resistance, Microbial; Fluconazole; Flucytosine; H

1993
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans;

1993
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1994, Feb-18, Volume: 36, Issue:916

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole

1994
[Fungal meningitis caused by a Malassezia species masquerading as painful ophthalmoplegia].
    Rinsho shinkeigaku = Clinical neurology, 1993, Volume: 33, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; M

1993
Pharmacokinetics of antifungal agents.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1993, Volume: 13 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritone

1993
Successful treatment of fungal peritonitis with intracatheter antifungal retention.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1995, Volume: 11

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Flucytos

1995
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1996, Feb-02, Volume: 38, Issue:967

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole

1996
Trichoderma harzianum peritonitis in peritoneal dialysis.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabeti

1996
[Focusing on therapy of systemic mycoses].
    Der Internist, 1995, Volume: 36, Issue:12 Suppl

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Dose-Response

1995
Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.
    The British journal of dermatology, 1997, Volume: 136, Issue:6

    Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Female; Flucytosine; Foot Diseases; Humans; Itr

1997
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
    Diagnostic microbiology and infectious disease, 1995, Volume: 23, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Hum

1995
Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Hematologic Neoplasms; Humans; Mycoses

1997
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity T

1998
In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Amphotericin B; Animals; Antibiotics, Antitubercular; Antifungal Agents; Drug Therapy, Combination;

1999
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
    Revista clinica espanola, 1999, Volume: 199, Issue:6

    Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional S

1999
Systemic phaeohyphomycosis in pregnancy and the puerperium.
    The West Indian medical journal, 2000, Volume: 49, Issue:1

    Topics: Adult; Antifungal Agents; Ascomycota; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy;

2000
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
    Mycoses, 1999, Volume: 42 Suppl 2

    Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Dr

1999
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
    Mycopathologia, 1999, Volume: 148, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot T

1999
[Visceral mycotic infections. In clinical practice].
    La Revue du praticien, 2001, Apr-15, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasm

2001
[Fungal infections in intensive care units: a cross-survey].
    Annales francaises d'anesthesie et de reanimation, 2001, Volume: 20, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Fluconazole; Flucy

2001
Trichosporon sepsis and leukemia.
    Cancer, 1975, Volume: 36, Issue:3

    Topics: Amphotericin B; Anti-Bacterial Agents; Bleomycin; Child; Cytarabine; Enterobacteriaceae Infections;

1975
Torulopsis glabrata--urinary tract infections in diabetic patients in Singapore.
    Australian and New Zealand journal of medicine, 1977, Volume: 7, Issue:1

    Topics: Adult; Aged; Amphotericin B; Candida; Diabetes Complications; Female; Flucytosine; Humans; Middle Ag

1977
Maxillary sinus infection with Allescheria boydii (Petriellidium boydii).
    The Johns Hopkins medical journal, 1978, Volume: 142, Issue:4

    Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Face; Flucytosine; Humans; Leukemia, Lymphoid; Male; M

1978
Treatment of systemic mycoses. Panel discussion.
    Scandinavian journal of infectious diseases. Supplementum, 1978, Issue:16

    Topics: Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Humans; Mycoses

1978
Mycotic wound infections. A new challenge of the surgeon.
    Archives of surgery (Chicago, Ill. : 1960), 1979, Volume: 114, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Female; Flucytosine; Humans; Leukemia,

1979
[Diagnosis and therapy of generalized mycoses].
    Medizinische Klinik, 1978, Mar-24, Volume: 73, Issue:12

    Topics: Amphotericin B; Flucytosine; Humans; Mycoses; Natamycin; Nystatin; Serologic Tests; Skin Tests; Spec

1978
Therapy of postsurgical fungal endophthalmitis.
    Ophthalmology, 1978, Volume: 85, Issue:4

    Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cataract Extraction; Eye Diseases;

1978
Fusarium oxysporum endophthalmitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1979, Volume: 97, Issue:1

    Topics: Adult; Amphotericin B; Drug Resistance, Microbial; Drug Therapy, Combination; Electroretinography; E

1979
[Fungal infections following renal transplantation].
    Mikrobiyoloji bulteni, 1977, Volume: 11, Issue:3

    Topics: Amphotericin B; Flucytosine; Humans; Immunosuppression Therapy; Kidney Transplantation; Miconazole;

1977
Recent advances in the treatment of systemic mycotic infections.
    Surgery, gynecology & obstetrics, 1979, Volume: 148, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine;

1979
Diagnosis and management of opportunistic infections. Part II. Diagnosis and therapy.
    Comprehensive therapy, 1977, Volume: 3, Issue:2

    Topics: Amphotericin B; Anaerobiosis; Anti-Infective Agents; Bacterial Infections; Flucytosine; Humans; Infe

1977
[Therapy of opportunistic mycoses].
    Dermatologica, 1979, Volume: 159, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Drug Evaluation; Econazole; Flucytosine; Humans; Miconazol

1979
[Recent progress in the treatment of systemic mycotic infections].
    Acquisitions medicales recentes, 1979

    Topics: Antifungal Agents; Clotrimazole; Econazole; Flucytosine; Humans; Miconazole; Mycoses

1979
Mycoses imported from the West Indies. A report of three cases.
    Postgraduate medical journal, 1979, Volume: 55, Issue:647

    Topics: Adult; Chromoblastomycosis; Emigration and Immigration; Female; Flucytosine; Histoplasmosis; Humans;

1979
The role of chemotherapy in the management of fungal endocaridits following homograft valve replacement.
    Postgraduate medical journal, 1979, Volume: 55, Issue:647

    Topics: Amphotericin B; Endocarditis; Flucytosine; Heart Valves; Humans; Mycoses; Postoperative Complication

1979
Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
    Proceedings of the Clinical Dialysis and Transplant Forum, 1979, Volume: 9

    Topics: Amphotericin B; Ascitic Fluid; Cryptococcus; Cytosine; Flucytosine; Humans; Kidney Failure, Chronic;

1979
Torulopsis glabrata fungaemia. A report of two cases.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1977, Apr-30, Volume: 51, Issue:18

    Topics: Adult; Amphotericin B; Candida; Drug Therapy, Combination; Flucytosine; Humans; Male; Middle Aged; M

1977
[Iatrogenic mycoses with deep visceral localization caused by opportunistic fungi].
    Dermatologica, 1979, Volume: 159, Issue:Suppl 1

    Topics: Amphotericin B; Candida; Candidiasis; Cryptococcosis; Dermatomycoses; Endocarditis; Flucytosine; Hum

1979
The current status of chemotherapeutic agents for the systemic mycoses.
    Contributions to microbiology and immunology, 1977, Volume: 4

    Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Myc

1977
[Incidence and therapy of fungal infections of the efferent urinary pathways].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Aug-15, Volume: 32, Issue:16

    Topics: Aged; Female; Flucytosine; Germany, East; Humans; Mycoses; Pyelonephritis; Urinary Tract Infections;

1977
[Clinical results in the management of mycoses using 5-fluorocytosine].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Sep-01, Volume: 32, Issue:17

    Topics: Age Factors; Antifungal Agents; Candidiasis; Child; Cytosine; Flucytosine; Humans; Mycoses

1977
[Results of cellular immune reaction assessment under 5-fluorocytosine therapy].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Sep-01, Volume: 32, Issue:17

    Topics: Child; Cytosine; Flucytosine; Humans; Immunity, Cellular; Lymphocyte Activation; Mycoses

1977
[Microbiological and clinical aspects of antifungal therapy].
    Advances in clinical pharmacology, 1977, Volume: 14

    Topics: Amphotericin B; Animals; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Micr

1977
[Critical remarks to the hospital on antifungal chemotherapy].
    Advances in clinical pharmacology, 1977, Volume: 14

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos

1977
[Combination of amphotericin B and 5-fluorocytosine].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1978, May-10, Volume: 98, Issue:13

    Topics: Amphotericin B; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Mycoses

1978
Drugs for the treatment of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1978, Jul-28, Volume: 20, Issue:15

    Topics: Amphotericin B; Clotrimazole; Drug Therapy, Combination; Flucytosine; Humans; Kidney Diseases; Menin

1978
Combined treatment with amphotericin B and flucytosine in severe fungal infections.
    The Journal of antimicrobial chemotherapy, 1976, Volume: 2, Issue:3

    Topics: Adult; Aged; Amphotericin B; Candida albicans; Candidiasis; Cytosine; Drug Therapy, Combination; Eye

1976
Bone marrow toxicity associated with 5-fluorocytosine therapy.
    Antimicrobial agents and chemotherapy, 1977, Volume: 11, Issue:2

    Topics: Adult; Aged; Bone Marrow Diseases; Cytosine; Female; Flucytosine; Humans; Kidney Diseases; Leukopeni

1977
Amphotericin B: a second look.
    Comprehensive therapy, 1977, Volume: 3, Issue:7

    Topics: Amphotericin B; Animals; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fl

1977
[New Drugs: Ancotil Roche].
    Der Urologe. Ausg. A, 1977, Volume: 16, Issue:5

    Topics: Chemical Phenomena; Chemistry; Cytosine; Flucytosine; Humans; Mycoses

1977
[5-fluorocytosine--a new antimycotic drug].
    Lakartidningen, 1976, Jun-16, Volume: 73, Issue:25

    Topics: Chemical Phenomena; Chemistry; Cytosine; Drug Evaluation; Flucytosine; Humans; Microbial Sensitivity

1976
Brain abscess caused by Cladosporium trichoides.
    Archives of internal medicine, 1976, Volume: 136, Issue:4

    Topics: Adolescent; Adult; Autopsy; Brain Abscess; Cladosporium; Female; Flucytosine; Humans; Male; Middle A

1976
Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.
    The American journal of medicine, 1976, Volume: 61, Issue:5

    Topics: Adult; Aged; Amphotericin B; Ascomycota; Disease Susceptibility; Female; Flucytosine; Humans; Male;

1976
[Therapy of generalized juvenile mycoses].
    Zeitschrift fur arztliche Fortbildung, 1976, Jun-15, Volume: 70, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Drug Resistance; Flucytosine; Griseofulvin;

1976
[Treatment of mycoses in children with 5-fluorocytosine].
    Padiatrie und Grenzgebiete, 1976, Volume: 15, Issue:5

    Topics: Child; Child, Preschool; Cytosine; Drug Evaluation; Female; Flucytosine; Humans; Infant; Infant, New

1976
Brain abscess caused by Cladosporium trichoides (Bantianum): a case with paranasal sinus involvement.
    Southern medical journal, 1976, Volume: 69, Issue:11

    Topics: Brain Abscess; Cladosporium; Flucytosine; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Sinu

1976
New drugs for the systemic mycoses: flucytosine and clotrimazole.
    Bulletin of the New York Academy of Medicine, 1975, Volume: 51, Issue:9

    Topics: Clotrimazole; Cytosine; Flucytosine; Humans; Imidazoles; Mycoses

1975
Amphotericin B. Old drug, new therapy.?2110.
    JAMA, 1975, May-12, Volume: 232, Issue:6

    Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Candida albicans; Cell Membrane Permeability; Crypt

1975
Editoral: Treatment of fungal infections.
    Archives of internal medicine, 1975, Volume: 135, Issue:2

    Topics: Amphotericin B; Aspergillus; Candida; Candida albicans; Cryptococcus neoformans; Cytosine; Drug Ther

1975
Fungal infection following renal transplantation.
    Archives of internal medicine, 1975, Volume: 135, Issue:9

    Topics: Adolescent; Adult; Amphotericin B; Antibodies, Fungal; Aspergillosis; Bacterial Infections; Candidia

1975
Flucytosine.
    Drug and therapeutics bulletin, 1975, Jan-03, Volume: 13, Issue:1

    Topics: Cytosine; Flucytosine; Humans; Mycoses

1975
New antifungal drugs.
    Drugs, 1975, Volume: 9, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Chlorobenzenes; Clotrimazole; Flucytosine; Humans; Imidazoles; Me

1975
Invasive fungal infection in the immunosuppressed host.
    International journal of clinical pharmacology and biopharmacy, 1975, Volume: 11, Issue:4

    Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Clotrimazole; Cryptococcosis; Flu

1975
Therapeutic usefulness. 5-Fluorocytosine--a new anti-fungal agent.
    The Journal of the Kansas Medical Society, 1975, Volume: 76, Issue:5

    Topics: Adult; Aged; Amphotericin B; Candida; Cryptococcosis; Cytosine; Drug Therapy, Combination; Female; F

1975
Fungal endocarditis: analysis of 24 cases and review of the literature.
    Medicine, 1975, Volume: 54, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Candida; Candidiasis; Cardiac Surgical Proce

1975
[Current problems and new developments in therapy of mycoses (author's transl)].
    Immunitat und Infektion, 1975, Volume: 3, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Clotrimazole; Cryptococcosis; Dermatomycoses; Drug R

1975
[Therapeutic use of antimycotic substances].
    Schweizerische medizinische Wochenschrift, 1976, Mar-27, Volume: 106, Issue:13

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Burns; Cardiac Surgical Procedures; Cathet

1976
[Identification and special treatment of generalized mycoses].
    Die Medizinische Welt, 1976, Apr-23, Volume: 27, Issue:17

    Topics: Amphotericin B; Clotrimazole; Flucytosine; Humans; Mycoses

1976
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1992, Feb-21, Volume: 34, Issue:864

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole

1992
Tropical mycoses.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal

1992
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy

1992
Hyalohyphomycosis caused by Paecilomyces variotii: a case report, animal pathogenicity and 'in vitro' sensitivity.
    Antonie van Leeuwenhoek, 1992, Volume: 62, Issue:3

    Topics: Adult; Animals; Antifungal Agents; Cortisone; Dermatomycoses; Flucytosine; Humans; Immunocompromised

1992
[Clinical evaluation of flucytosine in patients with urinary fungal infections].
    The Japanese journal of antibiotics, 1992, Volume: 45, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Candida; Candidiasis; Drug Evaluation; Drug Resistance, Microbial; F

1992
Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1991, Volume: 29, Issue:5

    Topics: Amphotericin B; Brain; Brain Abscess; Fluconazole; Flucytosine; Humans; Lymphoma, Large B-Cell, Diff

1991
Aureobasidium infection of the jaw.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1991, Volume: 20, Issue:4

    Topics: Adult; Flucytosine; Humans; Male; Mandibular Diseases; Mitosporic Fungi; Molar, Third; Mycoses; Oste

1991
[Drug therapy of intractable mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Dec-10, Volume: 79, Issue:12

    Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucy

1990
[Endophthalmitis due to Fusarium: an uncommon cause].
    Bulletin de la Societe belge d'ophtalmologie, 1990, Volume: 239

    Topics: Adult; Amphotericin B; Endophthalmitis; Female; Flucytosine; Fusarium; Humans; Mycoses; Vitrectomy

1990
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Dr

1990
Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
    Postgraduate medicine, 1990, Volume: 88, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Cryptoco

1990
[Antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:10

    Topics: Administration, Oral; Amphotericin B; Fluconazole; Flucytosine; Humans; Infusions, Intravenous; Inje

1990
Fusarium peritonitis in peritoneal dialysis: report of two cases.
    Microbiologica, 1990, Volume: 13, Issue:1

    Topics: Aged; Catheters, Indwelling; Female; Flucytosine; Fusarium; Humans; Male; Mycoses; Peritoneal Dialys

1990
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.
    The Journal of pediatrics, 1990, Volume: 116, Issue:5

    Topics: Amphotericin B; Candidiasis; Flucytosine; Gestational Age; Humans; Infant, Low Birth Weight; Infant,

1990
First report of chronic meningitis caused by Trichosporon beigelii.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:3

    Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu

1990
Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy.
    Cancer, 1990, Jun-15, Volume: 65, Issue:12

    Topics: Adult; Amphotericin B; Drug Combinations; Flucytosine; Humans; Leukemia, Myeloid, Acute; Lymphoma, N

1990
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1990, Jun-15, Volume: 32, Issue:820

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole

1990
A case of disseminated phaeohyphomycosis caused by Cladosporium devriesii.
    The West Indian medical journal, 1990, Volume: 39, Issue:2

    Topics: Adult; Amphotericin B; Cause of Death; Cladosporium; Female; Flucytosine; Humans; Mycoses; Recurrenc

1990
[Mycoses in otorhinolaryngology. Apropos of 167 cases].
    Revue de laryngologie - otologie - rhinologie, 1989, Volume: 110, Issue:2

    Topics: Adult; Antifungal Agents; Child; Child, Preschool; Cote d'Ivoire; Female; Flucytosine; Humans; Infan

1989
[Treatment of mycoses and new antifungal agents].
    La Revue du praticien, 1989, Sep-01, Volume: 39, Issue:19

    Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itra

1989
Fungal peritonitis in children on continuous ambulatory peritoneal dialysis.
    Scottish medical journal, 1989, Volume: 34, Issue:4

    Topics: Adolescent; Amphotericin B; Candidiasis; Child; Child, Preschool; Cryptococcosis; Female; Flucytosin

1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy

1987
Infection and colonisation of neonates by Hansenula anomala.
    Lancet (London, England), 1986, Feb-08, Volume: 1, Issue:8476

    Topics: Amphotericin B; Disease Outbreaks; Drug Therapy, Combination; England; Flucytosine; Gestational Age;

1986
[Decrease in systemic fungal infections in hematological neoplasms with empirical use of amphotericin B therapy].
    Schweizerische medizinische Wochenschrift, 1989, Jan-14, Volume: 119, Issue:2

    Topics: Amphotericin B; Creatinine; Drug Therapy, Combination; Flucytosine; Humans; Leukemia, Myeloid, Acute

1989
Intracranial phycomycosis: case reports.
    Neurosurgery, 1988, Volume: 23, Issue:1

    Topics: Adult; Amphotericin B; Biopsy; Brain Diseases; Female; Flucytosine; Humans; Male; Middle Aged; Mycos

1988
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
    The American review of respiratory disease, 1988, Volume: 138, Issue:4

    Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles

1988
Parenteral 5-fluorocytosine in the therapy of systemic mycoses.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Amphotericin B; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Infant,

1988
Drugs for treatment of deep fungal infection.
    The Medical letter on drugs and therapeutics, 1988, Mar-11, Volume: 30, Issue:761

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op

1988
Rhodotorula rubra ventriculitis.
    The Journal of infection, 1988, Volume: 16, Issue:2

    Topics: Adult; Amphotericin B; Cerebral Ventricles; Encephalitis; Female; Flucytosine; Humans; Immune Tolera

1988
[Antimycotic agents in generalized fungal infections].
    Nederlands tijdschrift voor geneeskunde, 1988, May-14, Volume: 132, Issue:20

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycos

1988
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
    Cancer, 1986, Oct-15, Volume: 58, Issue:8

    Topics: Adult; Amphotericin B; Combined Modality Therapy; Flucytosine; Humans; Leukemia, Monocytic, Acute; M

1986
[Fungal urinary infection: report no. 1].
    Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Candida; Drug Resistance, Microbial; Flucytosine; Humans; Middle Age

1986
Cerebral phaeohyphomycosis.
    Bulletin de la Societe de pathologie exotique et de ses filiales, 1987, Volume: 80, Issue:3

    Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans;

1987
The high morbidity of CAPD fungal peritonitis--description of 10 cases and review of treatment strategies.
    The Quarterly journal of medicine, 1986, Volume: 61, Issue:235

    Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Female; Flucytosine; Humans; Kidney Failure, Chr

1986
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1987, Volume: 62, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles

1987
In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation; Flucytosine; Human

1987
Fungal endophthalmitis in narcotic abusers. Medical and surgical therapy in 10 patients.
    The Medical journal of Australia, 1985, Apr-01, Volume: 142, Issue:7

    Topics: Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Female; Flucytosine;

1985
Ketoconazole: clinical evaluation in severe fungal infections.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male;

1986
Drugs for treatment of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1986, Apr-11, Volume: 28, Issue:711

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans

1986
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
    American journal of nephrology, 1985, Volume: 5, Issue:3

    Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine;

1985
Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD?
    Nephron, 1985, Volume: 40, Issue:2

    Topics: Candida; Catheters, Indwelling; Flucytosine; Humans; Mycoses; Peritoneal Dialysis; Peritoneal Dialys

1985
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Three recoveries in 5 cases without catheter removal.
    Nephron, 1985, Volume: 41, Issue:2

    Topics: Adult; Aged; Amphotericin B; Catheterization; Drug Therapy, Combination; Female; Flucytosine; Humans

1985
Deep scopulariopsosis: a case report and sensitivity studies.
    Journal of clinical pathology, 1974, Volume: 27, Issue:10

    Topics: Adult; Amphotericin B; Ankle Joint; Antimony; Chronic Disease; Female; Flucytosine; Granulation Tiss

1974
Fungal infections.
    Clinical pharmacology and therapeutics, 1974, Volume: 16, Issue:5 Part 2

    Topics: Antifungal Agents; Culture Media; Drug Resistance, Microbial; Drug Stability; Flucytosine; Fungi; Hu

1974
Current and future chemotherapy of central nervous system fungal infections.
    Advances in neurology, 1974, Volume: 6

    Topics: Administration, Oral; Amphotericin B; Arrhythmias, Cardiac; Brain Diseases; Cytosine; Flucytosine; G

1974
Chemotherapy of the systemic mycoses.
    American family physician, 1973, Volume: 7, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; H

1973
Systemic mycoses in children. II.
    Current problems in pediatrics, 1972, Volume: 3, Issue:1

    Topics: Actinomycosis; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female;

1972
Postoperative fungal endocarditis. Fungemia, embolism, and therapy.
    Archives of internal medicine, 1974, Volume: 134, Issue:1

    Topics: Aged; Amphotericin B; Aortic Valve; Aspergillus; Blood; Candida; Candida albicans; Cryptococcus; Emb

1974
Therapy of deep-seated fungal infections with 5-fluorocytosine.
    Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:5

    Topics: Adult; Aged; Amphotericin B; Anterior Chamber; Aspergillosis; Aspergillus fumigatus; Candida albican

1974
Synergism of amphotericin B with other antimicrobial agents.
    Annals of internal medicine, 1973, Volume: 78, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Humans; Mycoses; Rifampin

1973
Treatment of systemic mycoses.
    Medicine, 1973, Volume: 52, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cr

1973
The treatment of systemic mycoses.
    Rational drug therapy, 1973, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Potassium Iodide; Stilbamidines

1973
Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.
    Antimicrobial agents and chemotherapy, 1973, Volume: 3, Issue:1

    Topics: Animals; Antifungal Agents; Cytosine; Flucytosine; Male; Mice; Mitosporic Fungi; Mycoses; Sporotrich

1973
Bronchopulmonary geotrichosis.
    The American review of respiratory disease, 1973, Volume: 108, Issue:6

    Topics: Aged; Amphotericin B; Bronchial Diseases; Colistin; Flucytosine; Geotrichosis; Humans; Lung Diseases

1973
Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.
    Annals of internal medicine, 1974, Volume: 80, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Blood Proteins; Cholesterol; Creatinine; Cytosine; Flucyto

1974